These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35491428)

  • 21. The prevalence of nontherapeutic and dangerous international normalized ratios among patients receiving warfarin in the emergency department.
    Newman DH; Zhitomirsky I
    Ann Emerg Med; 2006 Aug; 48(2):182-9, 189.e1. PubMed ID: 16953531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of prophylactic oseltamivir on INR in patients on stable warfarin therapy.
    Smith KR; Bryan WE; Townsend ML; Randolph AE; Vanderman AJ; Woodard CL; Brown JN
    J Thromb Thrombolysis; 2020 Aug; 50(2):452-456. PubMed ID: 31898274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.
    Hylek EM; Chang YC; Skates SJ; Hughes RA; Singer DE
    Arch Intern Med; 2000 Jun; 160(11):1612-7. PubMed ID: 10847254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of amiodarone on warfarin anticoagulation: a register-based nationwide cohort study involving the Swedish population.
    Holm J; Lindh JD; Andersson ML; Mannheimer B
    J Thromb Haemost; 2017 Mar; 15(3):446-453. PubMed ID: 28058824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonadherence with INR monitoring and anticoagulant complications.
    Witt DM; Delate T; Clark NP; Garcia DA; Hylek EM; Ageno W; Dentali F; Crowther MA
    Thromb Res; 2013 Aug; 132(2):e124-30. PubMed ID: 23800635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Vitamin K Administration on Elevated International Normalized Ratio in Chronic Liver Disease.
    Smith CB; Hennessey EK; Crossey CD; Crannage AJ
    Clin Appl Thromb Hemost; 2023; 29():10760296231164642. PubMed ID: 37093741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Warfarin for atrial fibrillation in community-based practise.
    Rose AJ; Ozonoff A; Henault LE; Hylek EM
    J Thromb Haemost; 2008 Oct; 6(10):1647-54. PubMed ID: 18853483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correction factor to improve agreement between point-of-care and laboratory International Normalized Ratio values.
    Johnson SA; Vazquez SR; Fleming R; Lanspa MJ
    Am J Health Syst Pharm; 2017 Jan; 74(1):e24-e31. PubMed ID: 28007718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Warfarin-antibiotic interactions in older adults of an outpatient anticoagulation clinic.
    Ghaswalla PK; Harpe SE; Tassone D; Slattum PW
    Am J Geriatr Pharmacother; 2012 Dec; 10(6):352-60. PubMed ID: 23089199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation.
    Pokorney SD; Holmes DN; Thomas L; Fonarow GC; Kowey PR; Reiffel JA; Singer DE; Freeman JV; Gersh BJ; Mahaffey KW; Hylek EM; Naccarelli GV; Ezekowitz MD; Piccini JP; Peterson ED;
    JAMA Cardiol; 2019 Aug; 4(8):756-764. PubMed ID: 31268487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variables associated with adequate INR reversal in warfarin treated patients receiving 4-factor prothrombin complex concentrate.
    Kjerengtroen S; Chauv S; Hickman AW; Collingridge DS; Fontaine GV
    J Thromb Thrombolysis; 2022 Aug; 54(2):268-275. PubMed ID: 35378715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin users.
    Witt DM; Delate T; Clark NP; Martell C; Tran T; Crowther MA; Garcia DA; Ageno W; Hylek EM;
    J Thromb Haemost; 2010 Apr; 8(4):744-9. PubMed ID: 20398186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A re-appraisal of warfarin control in the treatment of deep vein thrombosis and / or pulmonary embolism.
    Amiwero C; Campbell IA; Prescott RJ
    Afr Health Sci; 2009 Sep; 9(3):179-85. PubMed ID: 20589148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of oseltamivir on bleeding risk associated with warfarin therapy: a retrospective review.
    Lee SH; Kang HR; Jung JW; Kwon JW; Hong KS; Yu KS; Cho SH
    Clin Drug Investig; 2012 Feb; 32(2):131-7. PubMed ID: 22149150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator.
    Xian Y; Liang L; Smith EE; Schwamm LH; Reeves MJ; Olson DM; Hernandez AF; Fonarow GC; Peterson ED
    JAMA; 2012 Jun; 307(24):2600-8. PubMed ID: 22735429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended International Normalized Ratio testing intervals for warfarin-treated patients.
    Barnes GD; Kong X; Cole D; Haymart B; Kline-Rogers E; Almany S; Dahu M; Ekola M; Kaatz S; Kozlowski J; Froehlich JB
    J Thromb Haemost; 2018 Jul; 16(7):1307-1312. PubMed ID: 29763979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of warfarin dosing in the intensive care unit following the Fontan procedure.
    Thomas CA; Taylor K; Schamberger MS; Rotta AT
    Congenit Heart Dis; 2014; 9(4):361-5. PubMed ID: 25247218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors of drug interaction between warfarin and nonsteroidal anti-inflammatory drugs in practical setting.
    Choi KH; Kim AJ; Son IJ; Kim KH; Kim KB; Ahn H; Lee EB
    J Korean Med Sci; 2010 Mar; 25(3):337-41. PubMed ID: 20191029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated International Normalized Ratio Is Associated With Ruptured Aneurysms.
    Can A; Castro VM; Dligach D; Finan S; Yu S; Gainer V; Shadick NA; Savova G; Murphy S; Cai T; Weiss ST; Du R
    Stroke; 2018 Sep; 49(9):2046-2052. PubMed ID: 30354989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.